Lipid Lowering Therapy, an essential aspect of cardiovascular care, is designed to address and control elevated cholesterol and triglyceride levels within the bloodstream. By employing various medications like statins, fibrates, or cholesterol absorption inhibitors, this therapeutic approach aims to bring about a significant reduction in lipid levels, thereby reducing the risk of cardiovascular diseases, including heart attacks and strokes. The significance of Lipid Lowering Therapy lies in its ability to curtail one of the primary risk factors associated with cardiovascular complications. Regular monitoring of lipid levels and the implementation of personalized treatment plans are key elements in ensuring the effectiveness of Lipid Lowering Therapy. Healthcare professionals tailor interventions based on individual patient profiles, considering factors such as age, medical history, and existing conditions. This personalized approach enhances the precision and success of the therapy, emphasizing its role in holistic cardiovascular management.
Title : Investigating the long-term follow up of atrial septal device closures in wales and england: A comparative analysis with major adverse cardiovascular Events (MACE)
Meera Gopinath, Cardiff University Medical school, United Kingdom
Title : An adult case of polysplenia syndrome associated with sinus node dysfunction
Apoorva Tripathi, Oxford University Hospitals, United Kingdom
Title : A unique cell-driven phenomenon in the heart and the promising future of the innovative translational tools to manage cardiac self-renewal and regeneration
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Personalized and precision medicine (PPM) as a unique healthcare model through biodesign-driven translational applications and cardiology-related healthcare marketing to secure the human healthcare and biosafety
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Yasser’s criterion of inferior ST-segment discrepancy deviations in AF with aberrancy and Sgarbosa criteria - a new cardiovascular discovery and management - a case report
Yasser Mohammed Hassanain Elsayed, Egyptian Ministry of Health, Egypt
Title : Successful treatment of sinus of valsalva aneurysm
Aina Jarillo, Universidad Anahuac Mexico Norte, Mexico